Skip to main content

Advertisement

Log in

Identification of MMACHC and PROKR2 mutations causing coexistent cobalamin C disease and Kallmann syndrome in a young woman

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Cobalamin C (cblC) disease and Kallmann syndrome (KS) are rare hereditary diseases. To date, no report has described the coexistence of those two genetic disorders in the same patient, or an association between them. We report the case of a 23-year-old woman with cblC defect and KS. She first presented mild memory problems in puberty, which worsened in adulthood to progressive memory loss accompanied by slow and unsteady walking, slow response, inattention, cognitive impairment, insomnia, no sense of smell, and the lack of spontaneous puberty. Laboratory tests revealed gonadotropin deficiency, a low estrogen level, and remarkably elevated serum homocysteine and serum and urine organic acid levels. Whole-exome sequencing detected compound heterozygous variants in MMACHC [c.398_399del (p.Gln133Argfs*4) and c.482G > A (p.Arg161Gln)] and heterozygous variants in PROKR2 [c.337T > C (p.Tyr113His)]. Thus, clinical and genetic examinations confirmed the cblC disease and KS diagnoses. This report on coexisting cblC disease and KS caused by different pathogenic genes in a single patient enriches the clinical research on these two rare genetic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

References

  • Abreu AP, Trarbach EB, de Castro M et al (2008) Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 93:4113–4118

    Article  CAS  Google Scholar 

  • Cole LW, Sidis Y, Zhang C et al (2008) Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 93:3551–3559

    Article  CAS  Google Scholar 

  • Fischer S, Huemer M, Baumgartner M et al (2014) Clinical presentation and outcome in a series of 88 patients with the cblC defect. J Inherit Metab Dis 37:831–840

    Article  CAS  Google Scholar 

  • Franceschini P, Licata D, Guala A et al (2002) Poland sequence and hyperhomocyst(e)inaemia. Prenat Diagn 22:634

    Article  Google Scholar 

  • Froese DS, Zhang J, Healy S et al (2009) Mechanism of vitamin B12-responsiveness in cblC methylmalonic aciduria with homocystinuria. Mol Genet Metab 98:338–343

    Article  CAS  Google Scholar 

  • Ha JH, Lee S, Kim Y et al (2017) Kallmann syndrome with a Tyr113His PROKR2 mutation. Medicine (Baltim) 96:e7974

    Article  CAS  Google Scholar 

  • Haijes HA, Jans J, Tas SY et al (2019) Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications. J Inherit Metab Dis 42:730–744

    Article  CAS  Google Scholar 

  • Huemer M, Scholl-Bürgi S, Hadaya K et al (2014) Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet J Rare Dis 9:161

    Article  Google Scholar 

  • Huemer M, Diodato D, Schwahn B et al (2017) Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis 40:21–48

    Article  CAS  Google Scholar 

  • Laitinen EM, Vaaralahti K, Tommiska J et al (2011) Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis 6:41

    Article  Google Scholar 

  • Lerner-Ellis JP, Tirone JC et al (2006) Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 38:93–100

    Article  CAS  Google Scholar 

  • Martinelli D, Deodato F, Dionisi-Vici C (2011) Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis 34:127–135

    Article  CAS  Google Scholar 

  • Meczekalski B, Podfigurna-Stopa A, Smolarczyk R et al (2013) Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol 29:296–300

    Article  Google Scholar 

  • Perła-Kaján J, Jakubowski H (2019) Dysregulation of epigenetic mechanisms of gene expression in the pathologies of hyperhomocysteinemia. Int J Mol Sci 20:3140

    Article  Google Scholar 

  • Sarfati J, Dodé C, Young J (2010) Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations. Front Horm Res 39:121–132

    Article  CAS  Google Scholar 

  • Sbai O, Monnier C, Dodé C et al (2014) Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations. FASEB J 28:3734–3744

    Article  CAS  Google Scholar 

  • Stamou MI, Georgopoulos NA (2018) Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metabolism 86:124–134

    Article  CAS  Google Scholar 

  • Traboulsi W, Brouillet S, Sergent F et al (2015) Prokineticins in central and peripheral control of human reproduction. Horm Mol Biol Clin Investig 24:73–81

    CAS  PubMed  Google Scholar 

  • Wang SJ, Yan CZ, Wen B et al (2019) Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series. Neuropsychiatr Dis Treat 15:549–555

    Article  Google Scholar 

  • Weisfeld-Adams JD, Baker PR (2015) Co-occurrence of the Poland sequence in a patient with the cobalamin C defect: more than just a coincidence? J Inherit Metab Dis 38:365–366

    Article  Google Scholar 

  • Zhou X, Cui Y, Han J (2018) Methylmalonic acidemia: Current status and research priorities. Intractable Rare Dis Res 7:73–78

    Article  Google Scholar 

  • Zwickler T, Haege G, Riderer A et al (2012) Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? J Inherit Metab Dis 35:797–806

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank the patient and her family for allowing us to publish this case.

Funding

This study was funded by the National Natural Science Foundation of China (no. 81,801,160), Hunan Provincial Natural Science Foundation (no. 2018JJ3463), and Major Project of the Hunan Provincial Health Commission (no. A2017019).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization and editing were performed by Mei Yuan. Material preparation and data collection were performed by Sipeng Deng, Wei Gao and Haijun Yuan. The first draft of the manuscript was written by Haijun Yuan. All authors read, revised, and approved the final manuscript.

Corresponding author

Correspondence to Mei Yuan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

This study was approved by the Ethics Committee of the Second Hospital, University of South China (no. 180,136), and adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from the patient and her parents.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, H., Deng, S., Gao, W. et al. Identification of MMACHC and PROKR2 mutations causing coexistent cobalamin C disease and Kallmann syndrome in a young woman. Metab Brain Dis 36, 447–452 (2021). https://doi.org/10.1007/s11011-020-00654-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-020-00654-8

Keywords

Navigation